Genentech Seeks Preemption Summary Judgment In Herceptin Vial MDL
TULSA, Okla. — Genentech Inc. on Aug. 23 moved for summary judgment in the Herceptin vial multidistrict litigation, arguing that plaintiff claims that vials were underfilled are preempted by federal law...To view the full article, register now.
Already a subscriber? Click here to view full article